Antithymocyte Globulin as a Second Line Therapy in Graves Orbitopathy

NCT05199103 · clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Medical University of Silesia